Groundbreaking Advancement: Internationally Leading Automated Testing Line Commissioned at Our Hospital

    Amidst the vibrant summer season, a significant milestone in medical diagnostics was achieved. On the morning of July 8, the acceptance ceremony for the Autolas A-1 Series fully automated biochemical and immunoassay line, along with the inauguration of the "Autobio Intelligent Laboratory Demonstration Unit," was grandly held at Rizhao Hospital Affiliated to Qingdao University /Rizhao International Heart Hospital. The management teams and representatives from both institutions gathered to witness this pivotal step towards intelligent laboratory diagnostics.

    In his address, Executive Vice President Xiu Xianlun of the hospital stated, "The successful commissioning of the Autolas A-1 Series and the establishment of the intelligent laboratory demonstration unit mark a strategic advancement in our pursuit of precision medicine and the acceleration of smart hospital development. This state-of-the-art testing line will significantly reduce patient wait times through its exceptional speed and ensure precise and reliable results via intelligent quality control, thereby providing more efficient and trustworthy diagnostic services for clinical treatments and patients."

    Mr. Liu Jining, General Manager of Autobio's Ludong Regional Division, emphasized in his speech, "Autobio is committed to delivering outstanding products and services to our clients. We look forward to the Autolas A-1 Series fully automated line at Rizhao International Heart Hospital showcasing its core value in enhancing medical service quality and efficiency, thus supporting the hospital's high-quality development."

    Following the speeches, Hospital Operations Director Wu Xinjian and General Manager Liu Jining jointly signed the delivery documents. 

    Subsequently, Vice President Xiu Xianlun and General Manager Liu Jining unveiled the plaque for the "Autobio Intelligent Laboratory Demonstration Unit" at Rizhao Intrnational Heart Hospital, signifying a new phase in the collaboration between the two parties. 

    After the ceremony, attendees visited the Medical Laboratory Department to observe the Autolas A-1 Series fully automated line in operation. This domestically developed high-end equipment, integrating efficiency, precision, and intelligence, was smoothly and seamlessly processing samples. Its outstanding performance and intelligent management vividly demonstrated how modern technology is reshaping diagnostic workflows and enhancing medical efficiency.

    The successful commissioning of the Autolas A-1 Series and the establishment of the "Autobio Intelligent Laboratory Demonstration Unit" signify a new era in the intelligent and automated development of the laboratory at Rizhao International Heart Hospital. In the future, leveraging this advanced testing line, the hospital will continue to provide more efficient, precise, and reliable diagnostic support for clinical treatments and patient health, significantly improving regional cardiovascular disease diagnosis and treatment services, and injecting robust intelligent momentum into the construction of a "Healthy Rizhao."